Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) have submitted on Monday, November 30, 2020, a formal Application for Conditional Marketing Authorization (CMA) to the European Medicines Agency (EMA) for their mRNA vaccine candidate, BNT162b2, against COVID-19. This submission completes the rolling review process initiated on October 6, 2020, with nonclinical data and partial […]
BioNTech SE (“BioNTech”; Nasdaq: BNTX,) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma”; Stock Code: 600196.SH, 02196.HK) jointly announced that their lead mRNA COVID-19 vaccine candidate BNT162b2 will be evaluated in a Phase 2 clinical trial in Taizhou and Lianshui, Jiangsu Province, China. The Phase 2 clinical trial of BNT162b2 in China will be […]
—————————————————————————————————————- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine in high-risk populations in the U.S. by the middle […]
• Novartis enters into exclusive worldwide license with Mesoblast to develop, commercialize and manufacture remestemcel-L for treatment of acute respiratory distress syndrome (ARDS) and other indications • Addition of remestemcel-L could expand Novartis respiratory portfolio by adding potential first-in-class ARDS therapy using innovative cell-based technology with platform potential • Deal includes $50 million upfront cash […]
Pfizer and BioNTech plan to submit the efficacy and safety data from the study for peer-review in a scientific journal once analysis of the data is completed. Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine […]
Pfizer (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2 mRNA-based vaccine candidate against COVID-19 to European Union (EU) Member States, with an option for the European Commission to request an additional 100 million doses. Deliveries […]
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced that it will receive a grant of up to 375 million Euro from an initiative by the German Federal Ministry of Education and Research (BMBF) to support the accelerated development of SARS-CoV-2 vaccines. BioNTech will use the milestone-based BMBF funding to support its contribution to […]
Commissioner for Neighbourhood and Enlargement, Olivér Várhelyi, together with President of Serbia Aleksandar Vučić participated today in the virtual signing ceremony of a €70.2 million assistance programme by Serbian Minister of European integration Jadranka Joksimović and EU Head of Delegation to Serbia Sem Fabrizi. This programme is the first envelope of the EU’s Instrument for […]
The 7000 kits were urgently flown into Entebbe International Airport on special arrangement from the company’s head office in Kuwait National Aviation Services (NAS) (www.NAS.aero), a leading global aviation services provider, recently donated Rapid Diagnostic Testing (RDT) kits to the Covid-19 National Task Force formed by the Ugandan Ministry of Health. These IgG/IgM Antibody RDT […]
Ferrari’s efforts to address the coronavirus pandemic continue: the Company has launched a fundraiser to support the health system of the province of Modena and will be matching all of the donations made by its clients. The initiative is the result of shared efforts by the Company and its many international clients who, in the […]
Mercedes-Benz is ready: The COVID-19 pandemic is affecting everyone. Especially in times like these, it is important for Mercedes-Benz to meet its social responsibilities. The Group has therefore offered its support with the production of medical equipment. With the aid of 3D printers, individual components can be produced that are urgently needed in medical technology […]
Stratasys Ltd. (NASDAQ: SSYS) has announced a global mobilization of the company’s 3D printing resources and expertise to respond to the COVID-19 pandemic, spanning its Stratasys, GrabCAD, Stratasys Direct Manufacturing and partner network with donated printing capacity across all regions. The initial focus is on providing thousands of disposable face shields for use by medical […]
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Korean
Portuguese
Russian
Spanish